Speaker: Elizabeth Mongol-Gunter, VMD
Topic: "Verdinexor: A Novel Oral Therapy for Canine Lymphoma"
This lecture will discuss the novel class of drugs called SINE inhibitors, with emphasis on verdinexor (Laverdia-CA1). We will review SINE mechanism of action, along with a thorough review of the data leading to a reasonable expectation of efficacy and FDA conditional approval of Laverdia-CA1. We will also look at where this new oral option fits into specialty and primary care practice therapies as consideration for future use. The attendee will learn how to properly dose and safely dispense verdinexor as well as how to monitor the lymphoma patient on verdinexor, including how to address any potential adverse events.
Dinner Meeting
Firebirds Wood Fired Grill
1225 Churchmans Rd
Newark, DE 19713
302-366-7577
Wednesday, October 5, 2022
Check-In: 6:30 PM - 7:00 PM, Eastern
Presentation: 7:00 PM - 8:00 PM, Eastern
Register by: Monday, October 3, 2022
CE Credits: 1
Contact(s):
Tina Mah, Territory Manager
302-559-3584
Tina.Mah@dechra.com
Additional Notes: Veterinarians, Technicians, and Practice Managers are invited.
